Advertisement
U.S. markets open in 5 hours 9 minutes

Sunzen Biotech Berhad (0148.KL)

Kuala Lumpur - Kuala Lumpur Delayed Price. Currency in MYR
0.3200+0.0050 (+1.59%)
At close: 04:50PM MYT
Advertisement
Show:
Annual
Upgrade to begin using 40 years of financial statements and get so much more.

Income Statement

All numbers in thousands
Upgrade to begin using 40 years of financial statements and get so much more.
Breakdown
ttm
12/31/2022
12/31/2021
12/31/2020
Total Revenue
85,819
97,094
90,479
82,233
Cost of Revenue
-
73,169
74,577
74,239
Gross Profit
-
23,926
15,902
7,994
Operating Expense
17,141
18,845
16,753
25,209
Operating Income
4,685
5,081
-851.302
-17,215
Net Non Operating Interest Income Expense
-
-170.798
-214.537
-515.18
Pretax Income
8,673
7,462
3,705
-12,702
Tax Provision
2,965
2,695
1,768
208.879
Net Income Common Stockholders
4,942
3,749
680.135
-13,229
Diluted NI Available to Com Stockholders
4,942
3,749
680.135
-13,229
Basic EPS
0.01
0.01
0.00
-0.03
Diluted EPS
0.01
0.00
0.00
-0.03
Basic Average Shares
719,441
708,147
561,887
528,765
Diluted Average Shares
803,329
799,487
598,789
528,765
Total Operating Income as Reported
7,237
7,633
3,920
-12,187
Total Expenses
90,309
92,013
91,330
99,447
Net Income from Continuing & Discontinued Operation
4,942
3,749
680.135
-13,229
Normalized Income
4,815
3,607
-591.3344
-15,517
Interest Income
-
36.722
44.588
88.556
Interest Expense
225.52
207.52
259.125
603.736
Net Interest Income
-
-170.798
-214.537
-515.18
EBIT
8,899
7,670
3,964
-12,098
EBITDA
11,353
10,242
6,566
-9,439
Reconciled Cost of Revenue
-
73,169
74,577
74,239
Reconciled Depreciation
2,455
2,573
2,601
2,660
Net Income from Continuing Operation Net Minority Interest
4,961
3,749
680.135
-13,229
Total Unusual Items Excluding Goodwill
221.332
221.332
1,673
3,010
Total Unusual Items
221.332
221.332
1,673
3,010
Normalized EBITDA
11,132
10,021
4,893
-12,449
Tax Rate for Calcs
0
0
0
0
Tax Effect of Unusual Items
75.6673
79.9386
401.5166
722.4991